Login
$ABOS
$0.20 -$0.01 (4.25%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Daniel O’Connell Also a director
Chief Executive Officer
56 Not stated Not stated $1,863,567
Matthew Zuga
Chief Financial Officer and Chief Business Officer
60 Since 2021
5 years
Not stated $948,789
Jim Doherty
President and Chief Development Officer
58 Since 2024
2 years
Not stated $1,012,859
Russell Barton
Chief Operating Officer
68 Since 2021
5 years
Not stated Not reported
Eric Siemers
Chief Medical Officer
70 Since 2018
8 years
Not stated Not reported
Derek Meisner
Chief Legal Officer
55 Since 2022
4 years
2022 Not reported
Amy Schacterle
Chief Regulatory Officer, Head of Quality
59 Since 2024
2 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
7.4 years
from year joined
CEO also chairs the board
No
George Golumbeski, Ph.D.
Director Age On board Independent Committees Other public boards Pay Source
George Golumbeski, Ph.D.
68 2025
1 year
Independent None stated None stated Not stated
Daniel O’Connell
56 2006
20 years
Not independent None stated None stated Paid as CEO
Derrell Porter, M.D.
55 2023
3 years
Independent None stated Passage Bio., Inc. Not stated
Laura Stoppel, Ph.D.
40 2020
6 years
Independent
Nominating and Corporate Governance Committee · Chair
Artiva Biotherapeutics, Inc. Not stated
Nathan Fountain, M.D. III
63 2021
5 years
Independent None stated None stated Not stated
Kimberlee C. Drapkin
58 2022
4 years
Independent
Audit Committee · Chair
None stated Not stated
Jeffrey Ives, Ph.D.
75 2014
12 years
Independent
Compensation Committee · Chair
None stated Not stated
Sean Stalfort
56 2018
8 years
Independent None stated Verrica Pharmaceuticals, Inc., Taysha Gene Therapies, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support